Gastric bypass may alter how blood pressure meds work

NCT ID NCT03460327

Recruiting now Knowledge-focused Sponsor: Norwegian University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study investigates how bariatric surgery (gastric bypass or sleeve gastrectomy) changes the way the body absorbs candesartan, a drug used to treat high blood pressure. Researchers will measure candesartan levels in the blood of 12 people with severe obesity before and after surgery. The goal is to understand whether these common weight-loss procedures affect how well the medication works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: candesartan
What this could lead to: If this study finds that bariatric surgery changes how candesartan is absorbed, it could help doctors adjust doses for patients after surgery.
What could go wrong: This is a very small study (12 people) that only measures drug levels in the blood, not health outcomes. Results may not apply to other medications or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

morbid obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY, MORBID

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

St. Olavs University Hospital
RECRUITING

Trondheim, Norway

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.